<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/427B1416-2FB1-4395-B168-9A3E1C094736"><gtr:id>427B1416-2FB1-4395-B168-9A3E1C094736</gtr:id><gtr:name>Erlangen Nuremberg University</gtr:name><gtr:address><gtr:line1>Schlossplatz 4</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6B1CF78B-5968-4ED6-B1C4-0404AD6A8818"><gtr:id>6B1CF78B-5968-4ED6-B1C4-0404AD6A8818</gtr:id><gtr:name>Academy of Science of the Czech Republic</gtr:name><gtr:address><gtr:line1>Academy of Science of the Czech Republic</gtr:line1><gtr:line2>Narodni 3</gtr:line2><gtr:postCode>117 20</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Czech Republic</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EA377C44-230F-49AB-9191-92C561B03AB8"><gtr:id>EA377C44-230F-49AB-9191-92C561B03AB8</gtr:id><gtr:name>Greifswald University</gtr:name><gtr:address><gtr:line1>Domstra?e 11</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9F03121C-0FF5-4D75-B76B-ADC337768524"><gtr:id>9F03121C-0FF5-4D75-B76B-ADC337768524</gtr:id><gtr:name>Ninewells Hospital &amp; Medical School</gtr:name><gtr:address><gtr:line1>PO BOX 120</gtr:line1><gtr:line4>Dundee</gtr:line4><gtr:line5>Angus</gtr:line5><gtr:postCode>DD1 9SY</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BA3A71C5-069C-419B-8925-117C3DBF37D9"><gtr:id>BA3A71C5-069C-419B-8925-117C3DBF37D9</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Sadler</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG006792%2F1"><gtr:id>9E00C65B-086B-4A42-AD5B-1DA666D01046</gtr:id><gtr:title>Photoactivation strategies for delivery of platinum prodrugs; oxygen independent photodynamic therapy (PDT)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G006792/1</gtr:grantReference><gtr:abstractText>People suffering from cancer are typically treated with either surgery, radiotherapy or chemotherapy. Currently the world's most widely used chemotherapeutic drugs are platinum-based; a leading example is cisplatin, a compound containing platinum with a 2+ charge. It is generally accepted that the anticancer activity of cisplatin and other closely related platinum compounds arises from their ability to damage DNA in cancer cells leading to cell death.The existing platinum drugs are highly toxic to both healthy and cancerous cells in the body. As a result, serious side-effects of treatment are a frequent and serious problem in chemotherapy. These side-effects can be so severe that treatment has to be stopped, leading to treatment failure and ultimately to the death of the patient. In some cases the cancerous cells in the bodies of patients become resistant after repeated doses of the drugs; then the cells are not killed by the drug and the cancer is not cured. This research project aims to develop new platinum anticancer drugs which work in a different way to cisplatin. If the platinum drug could be made harmless until it enters the cancer cells and then be activated only in the tumour tissue, this would greatly reduce unwanted side-effects, allow treatment of cisplatin-resistant tumours, and may also allow treatment of a wider range of cancers. Our proposed strategy is a new one. We will use compounds containing platinum with a 4+ charge. These will not be reactive towards cells and must be converted to platinum 2+ compounds before they kill cells. We will activate them specifically in cancer and not in other normal cells using a directed fine beam of light. To introduce even greater selectivity for cancer cells, we will tag the compounds with labels that are selectively recognised and taken up by cancer cells in preference to normal cells (peptides, antibodies). Our strategy will introduce new mechanisms for killing cancer cells, just what is needed to circumvent resistance to current platinum drugs. Our encouraging preliminary data suggest that we can make compounds that are more effective than cisplatin itself.Exciting is the prospect of using new optical devices to activate our compounds. These photonic crystal fibres can deliver laser light of a very precise colour over long distances. This should lead to more controllable activation and perhaps the prospect of reaching internal sites of the human body which are currently inaccessible to irradiation.This research project aims to design (with the help of computer predictions), synthesise and characterise new photoactivatable platinum complexes. The synthesis of these complexes is anticipated to be challenging since they must be made without direct exposure to light. They will be tested for features such as stability, solubility and cell uptake, and their photoactive properties determined. Extensive investigation into the spectroscopic properties of these new complexes will be carried out and much use will be made of nuclear magnetic resonance techniques to understand the mechanisms through which these complexes change chemically following activation by light. We will also use standard chemical techniques such as mass spectrometry, UV-Vis spectroscopy, and X-ray crystallography to fully characterise our new compounds. The distribution of the platinum complexes within cells and the selective platination of DNA and proteins and activity of the complexes towards different types of cancer cells will also be investigated.Since longer wavelengths of light (e.g. red light) penetrate tissue more deeply than shorter (e.g. blue light); a challenge will be to design compounds which are activated by irradiation of light with these longer wavelengths. This may be possible through using compounds which are able to absorb two photons at once, or by careful design of the ligands on the complexes.</gtr:abstractText><gtr:fund><gtr:end>2011-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2008-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>418100</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences</gtr:department><gtr:description>Photoactivated antibiotics</gtr:description><gtr:id>D9499BEA-0992-4FE2-83BD-7FF9DF72436F</gtr:id><gtr:impact>Chemistry
Life Sciences</gtr:impact><gtr:outcomeId>546418b68602e4.74407094-1</gtr:outcomeId><gtr:partnerContribution>Provision of facilities for culture and assay of bacteria and their growth</gtr:partnerContribution><gtr:piContribution>Synthesis of photoactive ruthenium complexes. Determination of antibacterial activity in the presence and absence of light.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Ultra high resolution mass spectrometry</gtr:description><gtr:id>E842E0EC-DD38-4C0F-8395-702C9EE277AF</gtr:id><gtr:impact>Physical chemistry, medicinal inorganic chemistry
Mass spectrometry evidence for cisplatin as a protein cross-linking reagent
H. Li, Huilin, Y. Zhao, H.A. Phillips, Y. Qi, T-Y. Lin, P.J. Sadler, P. O'Connor
Analytical Chem. 2011, 83, 5369-5376.Use of Top-down and Bottom-up Fourier Transform Ion Cyclotron Resonance Mass Spectrometry for Mapping Calmodulin Sites modified by Platinum Anticancer Drug
H. Li , T-Y, Lin , S.L. Van Orden , Y. Zhao , M.P. Barrow , A.M. Pizarro , Y. Qi , P.J. Sadler , and P.B O'Connor
Anal. Chem. 2011, 83, 5369-5376. 

Protein Flexibility is Key to Cisplatin Crosslinking in Calmodulin
H. Li, S.A. Wells, J.E. Jimenez-Roldan, R.A. R&amp;ouml;mer, Y. Zhao, P.J. Sadler, P.B. O'Connor
Protein Science 2012, 21, 1269-1279.

Mapping the Protein-Binding Sites for Novel Iridium(III) Anticancer Complexes Using Electron Capture Dissociation
Y. Qi, Z. Liu, H. Li, P.J. Sadler, P.B. O'Connor
Rapid Comm. Mass Spec. 2013, 27, 2028-2032.

Insights into the Binding Sites of Organometallic Ruthenium
Anticancer Compounds on Peptides Using Ultra-High
Resolution Mass Spectrometry
R.H. Wills, A. Habtemariam, A.F. Lopez-Clavijo, M.P. Barrow,
P.J. Sadler, P.B. O'Connor
J. Am. Soc. Mass Spectrom. 2014, 25, 662-672.

Mass Spectrometric Strategies to Improve the Identification of Pt(II)-Modification Sites on Peptides and Proteins
H. Li, Huilin, J.R. Snelling, M.P. Barrow, P.J.Sadler, P. O'Connor
J. Amer. Soc. Mass Spec. 2014, 25. 1217-1227.</gtr:impact><gtr:outcomeId>54641ad8e5e984.71156366-1</gtr:outcomeId><gtr:partnerContribution>Characterisation of metallodrugs and their adducts with DNA, oligonucleotides, proteins and peptides by FT ICR MS, including the use ofseparation by nanoHPLC and a variety of ion fragmentation techniques</gtr:partnerContribution><gtr:piContribution>Synthesis and reactions of organometallic and photoactivated anticancer metal complexes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>28408</gtr:fundingRef><gtr:id>A88337AA-C9E8-47E9-A016-6A9282FE6F93</gtr:id><gtr:outcomeId>5ed477745ed47788</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1315811</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Research Council</gtr:description><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>247450</gtr:fundingRef><gtr:id>D69AF2BD-62C6-4919-90C0-744A83D6FA3C</gtr:id><gtr:outcomeId>5ec2376c5ec23780</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Public lectures- Cafe scientifique, Rotary club
Schools lectures in UK, Hong Kong and China
BBS News broadcast</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>B0792DEB-CAD6-4C92-A52C-C76707C63778</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56debe161d46c7.74927173</gtr:outcomeId><gtr:sector>Chemicals,Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Modulator for a Pharmacological Agent</gtr:description><gtr:grantRef>EP/G006792/1</gtr:grantRef><gtr:id>AB5F661E-CE2A-48D2-A628-DC58CF9AE43C</gtr:id><gtr:impact>Modulator for a Pharmacological Agent</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56de94a6a324e6.52526339</gtr:outcomeId><gtr:patentId>GB1215498.5</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Modulator for a Pharmacological Agent</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>We designed new photoactivatable platinum anticancer complexes with low toxicity in the dark and potent activity against cancer cells when irradiated with light.

Importantly we were able to synthesise them with good yields, show that they were water-soluble and could be activated by visible light in a range of cancer cells.

We developed multinuclear NMR and MS methods which allowed studies of their structures and reactivity in solution.

This research provided a stong basis for developing new collaborations in Europe include COST Action, and led to new work with complexes conjugated to cancer cell-targetting peptides which is on-going.

We arev hopeful that eventually we will advance towards clinical trials with our new platinum photochemotherapeutic agents.</gtr:description><gtr:exploitationPathways>Biologists are interested in testing our compounds for activity in surface cancer which are currently difficult to treat in the clinic such as oesophageal and bladder cancers. 

In this area access to funding for such translational work is still hard to find (since it is expensive) but we keep trying.</gtr:exploitationPathways><gtr:id>403F5114-54A5-4CF8-8FB5-DA7FA7C79A14</gtr:id><gtr:outcomeId>56dec19cef6ce2.04693368</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www2.warwick.ac.uk/fac/sci/chemistry/research/sadler/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5E49CAB1-A6D1-4809-B31D-ECF571E5FEDC</gtr:id><gtr:title>Fabrication of crystals from single metal atoms.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2798814a9df66f782f938e971cd44a9"><gtr:id>b2798814a9df66f782f938e971cd44a9</gtr:id><gtr:otherNames>Barry NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>546413ee64cdc6.27431158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB75EF4F-DF30-4798-97B4-CE0C36AD3F3B</gtr:id><gtr:title>Spin-labelled photo-cytotoxic diazido platinum(iv) anticancer complex.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84743cd573b2d09f9cf1a56b00f4fab8"><gtr:id>84743cd573b2d09f9cf1a56b00f4fab8</gtr:id><gtr:otherNames>Venkatesh V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>58c9bee313ae16.80872913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E6383F9-301C-48FB-98F8-7D2CADD443B6</gtr:id><gtr:title>Photochemistry in photonic crystal fiber nanoreactors.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d7ee71c25291f2dd45eecef304b4874"><gtr:id>0d7ee71c25291f2dd45eecef304b4874</gtr:id><gtr:otherNames>Chen JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc2fc2da86409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FBFDB93-B135-4C10-8C59-0948EDFDEE6B</gtr:id><gtr:title>Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f151602a2662d14f6fa9135784d6ebc5"><gtr:id>f151602a2662d14f6fa9135784d6ebc5</gtr:id><gtr:otherNames>Pracharova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>doi_53d01c01cc899966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C62266D-8625-4090-A9DA-AF8D40D5B1E6</gtr:id><gtr:title>Excited-State Dynamics of a Two-Photon-Activatable Ruthenium Prodrug.</gtr:title><gtr:parentPublicationTitle>Chemphyschem : a European journal of chemical physics and physical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37677a3a3f97a7d5ebb939ecf6f06f5c"><gtr:id>37677a3a3f97a7d5ebb939ecf6f06f5c</gtr:id><gtr:otherNames>Greenough SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1439-4235</gtr:issn><gtr:outcomeId>58c9bea0716e62.29790512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2466060-4C36-490B-8C74-CBCD64C93C00</gtr:id><gtr:title>A computational approach to tuning the photochemistry of platinum(IV) anticancer agents.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/170cd1b8b5c6e73beab43c6b17a5396f"><gtr:id>170cd1b8b5c6e73beab43c6b17a5396f</gtr:id><gtr:otherNames>Tai HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc3fc315e6665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50DCBBF7-1B4D-4F82-AEDE-941329EF54F1</gtr:id><gtr:title>Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides.</gtr:title><gtr:parentPublicationTitle>Journal of inorganic biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5239041b28b67ddcf728e869f627d4ae"><gtr:id>5239041b28b67ddcf728e869f627d4ae</gtr:id><gtr:otherNames>Cubo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0162-0134</gtr:issn><gtr:outcomeId>doi_53cffbffb5633cd9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88BFB999-AA9D-4085-B599-665B19813EC8</gtr:id><gtr:title>Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>doi_53d013013fab104b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B4F24F8-0666-4052-A4CA-1CF08FA51534</gtr:id><gtr:title>Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism.</gtr:title><gtr:parentPublicationTitle>Molecular cancer therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d438e49263d60c757e281eb04b7b124"><gtr:id>8d438e49263d60c757e281eb04b7b124</gtr:id><gtr:otherNames>Westendorf AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1535-7163</gtr:issn><gtr:outcomeId>doi_53d076076ab02d68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F58012C6-86CE-46FD-8F60-75EBD3CF3F0B</gtr:id><gtr:title>Tryptophan switch for a photoactivated platinum anticancer complex.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca6dcd97d8afe8ef262a467543e97d9a"><gtr:id>ca6dcd97d8afe8ef262a467543e97d9a</gtr:id><gtr:otherNames>Butler JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>doi_53d017017b73e577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A617098F-496D-4729-88F7-75820E3CCB55</gtr:id><gtr:title>Photo-isomerisation of alkenyl complexes of platinum(II): structural, spectroscopic, kinetic and computational investigations.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e377e98cf40c08a9686ac6e37b400582"><gtr:id>e377e98cf40c08a9686ac6e37b400582</gtr:id><gtr:otherNames>Barone CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>doi_53d0300304ad244c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62EE3274-8210-42F7-8888-DD497FEA418B</gtr:id><gtr:title>Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>doi_53d01c01cc9b9be6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B685997-4F78-4037-97E9-597A0A0178C1</gtr:id><gtr:title>A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex.</gtr:title><gtr:parentPublicationTitle>Metallomics : integrated biometal science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e7e6b5b2ae2c7ed9ca137ccdb8ad73d"><gtr:id>4e7e6b5b2ae2c7ed9ca137ccdb8ad73d</gtr:id><gtr:otherNames>Novohradsky V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-5901</gtr:issn><gtr:outcomeId>546413ede4f3a9.60785193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E80B719-90CE-48ED-8B35-E124676253EA</gtr:id><gtr:title>A potent trans-diimine platinum anticancer complex photoactivated by visible light.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>doi_53cfc1fc13759711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4381B423-6C4C-402E-BFBD-0F65951FA715</gtr:id><gtr:title>Proton Sponge Phosphanes: Reversibly Chargeable Ligands for ESI-MS Analysis</gtr:title><gtr:parentPublicationTitle>European Journal of Inorganic Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf843c6a2035b60da621abb3cc2ac3ca"><gtr:id>cf843c6a2035b60da621abb3cc2ac3ca</gtr:id><gtr:otherNames>Farrer N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53cfc4fc406e1b16</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AA7B3FB-5119-45C8-BFB4-496D5B04579A</gtr:id><gtr:title>Ultrafast photo-induced ligand solvolysis of cis-[Ru(bipyridine)2(nicotinamide)2](2+): experimental and theoretical insight into its photoactivation mechanism.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37677a3a3f97a7d5ebb939ecf6f06f5c"><gtr:id>37677a3a3f97a7d5ebb939ecf6f06f5c</gtr:id><gtr:otherNames>Greenough SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn><gtr:outcomeId>546413eea3b970.93438092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30297A0E-8B98-439B-826D-504E3EA60337</gtr:id><gtr:title>Protein flexibility is key to cisplatin crosslinking in calmodulin.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>doi_53cfc8fc887a479c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD852BE8-08EF-49B9-AA85-1E079A42CD7F</gtr:id><gtr:title>Mass spectrometry evidence for cisplatin as a protein cross-linking reagent.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>doi_53d013013f430504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E960A47-FFA9-44E7-A0A4-D3ACF695AAA3</gtr:id><gtr:title>A Photoactivatable Platinum(IV) Anticancer Complex Conjugated to the RNA Ligand Guanidinoneomycin.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8990160e5fec2a60d77343b9eac664d"><gtr:id>f8990160e5fec2a60d77343b9eac664d</gtr:id><gtr:otherNames>Shaili E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>58c9be76d06070.01562738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BB967D9-92C6-40B0-A587-3E427F9C457B</gtr:id><gtr:title>Platinum(iv) azido complexes undergo copper-free click reactions with alkynes.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>5a995b2e077bd9.34828940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48C0FD0B-AD65-41B7-8C48-F1F0E72F9D4F</gtr:id><gtr:title>Targeted delivery of platinum-based anticancer complexes.</gtr:title><gtr:parentPublicationTitle>Current opinion in chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca6dcd97d8afe8ef262a467543e97d9a"><gtr:id>ca6dcd97d8afe8ef262a467543e97d9a</gtr:id><gtr:otherNames>Butler JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1367-5931</gtr:issn><gtr:outcomeId>doi_53cfe7fe7f8bac62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D97477B-A3DF-4D85-8478-300DCF15A78C</gtr:id><gtr:title>Decomposition pathways for the photoactivated anticancer complex cis,trans,cis-[Pt(N3)2(OH)2(NH3)2]: insights from DFT calculations.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/973e3117c1d3d9d49a01fab3eba76c20"><gtr:id>973e3117c1d3d9d49a01fab3eba76c20</gtr:id><gtr:otherNames>Salassa L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn><gtr:outcomeId>doi_53d02b02be6f10a1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAAE2C9E-8499-44C9-86FA-71625992670A</gtr:id><gtr:title>Probing platinum azido complexes by 14N and 15N NMR spectroscopy.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc2fc2fe78c8b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>981DF4F1-A4E8-462F-8B67-22602CED3927</gtr:id><gtr:title>Assessment of the influence of intrinsic environmental and geographical factors on the bacterial ecology of pit latrines.</gtr:title><gtr:parentPublicationTitle>Microbial biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8703ad164021168fbb518a8586736317"><gtr:id>8703ad164021168fbb518a8586736317</gtr:id><gtr:otherNames>Torondel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1751-7915</gtr:issn><gtr:outcomeId>585d53112f74e7.08163375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3254CF16-512F-4CA9-987E-9DA95128BEE7</gtr:id><gtr:title>Mass spectrometric strategies to improve the identification of Pt(II)-modification sites on peptides and proteins.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society for Mass Spectrometry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1044-0305</gtr:issn><gtr:outcomeId>546413ee3b6ed8.40488752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0095641-918A-4399-92E0-8130CBF309C9</gtr:id><gtr:title>Insights into the binding sites of organometallic ruthenium anticancer compounds on peptides using ultra-high resolution mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society for Mass Spectrometry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/574345de03dc2f11e30497cdaed141ee"><gtr:id>574345de03dc2f11e30497cdaed141ee</gtr:id><gtr:otherNames>Wills RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1044-0305</gtr:issn><gtr:outcomeId>doi_53cfe0fe09a34311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FE75DA9-8336-4CE7-89A2-CDEB9DED0636</gtr:id><gtr:title>Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc3fc33137d38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8923479-A95B-4572-AA36-728A00286D00</gtr:id><gtr:title>Microfluidic integration of photonic crystal fibers for online photochemical reaction analysis.</gtr:title><gtr:parentPublicationTitle>Optics letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/896b72640b1dc79e65e98c1050055698"><gtr:id>896b72640b1dc79e65e98c1050055698</gtr:id><gtr:otherNames>Unterkofler S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0146-9592</gtr:issn><gtr:outcomeId>doi_53d0800802f015b3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A79C046-9A9F-428E-82B0-F9454E096442</gtr:id><gtr:title>Two-photon-activated ligand exchange in platinum(II) complexes.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>doi_53cfc1fc19287b77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>667526D8-7B01-4069-9E33-E02A94DD3900</gtr:id><gtr:title>Insights into the acid-base properties of Pt(IV)-diazidodiam(m)inedihyroxido complexes from multinuclear NMR spectroscopy.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c62263418b3c87157c183d94b3a276c2"><gtr:id>c62263418b3c87157c183d94b3a276c2</gtr:id><gtr:otherNames>Ronconi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc2fc2ec38390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7C3C30D-B839-4DA5-9586-7290448B9117</gtr:id><gtr:title>Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>doi_53d02c02c14442ca</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E4271E0-5D6A-4CED-A294-12E810B67323</gtr:id><gtr:title>An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdcac558fe5ac560f214ae332b25b04f"><gtr:id>fdcac558fe5ac560f214ae332b25b04f</gtr:id><gtr:otherNames>Gandioso A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>58c9bdfb268f31.04883780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF969CFF-A0AD-4241-9536-AB6F45E93A12</gtr:id><gtr:title>De novo generation of singlet oxygen and ammine ligands by photoactivation of a platinum anticancer complex.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>doi_53cfc1fc1adbcdda</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G006792/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>35</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>B30DC286-3309-48E2-A15D-BDF547057A33</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Drug Formulation &amp; Delivery</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>